)
Dame Sarah Gilbert is the Said Professor of Vaccinology in the Nuffield Department of Medicine at the University of Oxford, and co-founder of Vaccitech. She works on vaccines for many different emerging pathogens, including influenza, Nipah, MERS, Lassa, Crimean-Congo haemorrhagic fever, and in 2020, initiated the SARS-CoV-2 vaccine project.
Working with Oxford colleagues, she has taken novel vaccines from design to clinical development, with a particular interest in the rapid transfer of vaccines into manufacturing and first in human trials. She is the Oxford Project Leader for ChAdOx1 nCoV-19 (the AstraZeneca vaccine), a vaccine against the novel coronavirus, which is now in use in over 160 countries around the world.
Photo credit: John Cairns/University of Oxford
“It is wonderful to be awarded an honorary degree from the University at which I began my scientific career. I look forward to visiting the campus next year to see how things have changed.”